(S (NP-SBJ (DT A) (JJ chimeric) (NN type) (CD II) (: /) (NN type) (CD I) (NN interleukin-1) (NN receptor)) (VP (MD can) (VP (VB mediate) (NP (NP (NN interleukin-1) (NN induction)) (PP (IN of) (NP (NN gene) (NN expression))) (PP (IN in) (NP (NN T) (NNS cells)))))) (. .))
(S (NP-SBJ-100 (DT The) (NN type) (CD I) (NP (NP (NN interleukin-1) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN IL-1R)) (-RRB- -RRB-)))) (VP (VBZ is) (ADJP-PRD (JJ capable) (PP (IN of) (S (NP-SBJ (-NONE- *-100)) (VP (VBG transducing) (NP (NP (DT a) (NN signal)) (VP (VBG resulting) (PP (IN in) (NP (NP (NN promoter) (NN activation)) (PP (IN in) (NP (NN T) (NNS cells)))))))))))) (. .))
(S (NP-SBJ (DT This) (NN signal) (NN transduction)) (VP (VBZ is) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NP (DT the) (JJ cytoplasmic) (NN domain)) (, ,) (SBAR (WHNP-22 (WDT which)) (S (NP-SBJ (-NONE- *T*-22)) (VP (VBZ consists) (PP (IN of) (NP (CD 213) (NN amino) (NNS acids)))))))))) (. .))
(S (PP (IN In) (NN contrast) (TO to) (NP (DT the) (NN type) (CD I) (NN receptor))) (, ,) (S-COOD (S (NP-SBJ (DT the) (NN type) (CD II) (NN IL-1R)) (VP (VBZ has) (NP (DT a) (JJ small) (JJ cytoplasmic) (NN tail)))) (, ,) (CC and) (S (NP-SBJ (NP (PRP it)) (SBAR (-NONE- *EXP*-23))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ clear)) (SBAR-23 (IN whether) (S (NP-SBJ (DT this) (NN receptor)) (VP (VBZ is) (NP-PRD (NP-COOD (NP (DT a) (JJ signal-transducing) (NP (-NONE- *RNR*-101))) (CC or) (NP (DT a) (JJ regulatory) (NP (-NONE- *RNR*-101)))) (NP-101 (NN molecule))))))))) (. .))
(S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP-SBJ (DT the) (NN type) (CD II) (NN IL-1R)) (VP (VBZ does) (RB not) (VP (VB mediate) (NP (NP (NN gene) (NN activation)) (PP (IN in) (NP (NN Jurkat) (NNS cells))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-102 (NP (DT a) (NN hybrid) (NN receptor)) (VP (VBN composed) (NP (-NONE- *)) (PP (IN of) (NP (NP (DT the) (ADJP-COOD (ADJP (JJ extracellular)) (CC and) (ADJP (NN transmembrane))) (NNS regions)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN type) (CD II) (NN interleukin-1)) (VP (VBN fused) (NP (-NONE- *)) (PP (TO to) (NP (NP (DT the) (JJ cytoplasmic) (NN domain)) (PP (IN of) (NP (DT the) (JJ human) (NN type) (CD I) (NN IL-1R)))))))))))) (VP (VBD was) (ADJP-PRD (JJ capable) (PP (IN of) (S (NP-SBJ (-NONE- *-102)) (VP (VBG transducing) (NP (NP (DT a) (NN signal)) (VP (-NONE- *ICH*-105))) (PP (IN across) (NP (DT the) (NN membrane))) (VP-105 (VBG resulting) (PP (IN in) (NP (NP (DT a) (NN pattern)) (PP (IN of) (NP (NP (NN gene) (NN activation)) (ADJP (JJ identical) (PP (TO to) (NP (NP (DT that)) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN type) (CD I) (NN IL-1R))))))))))))))))) (. .))
(S (NP-SBJ (PRP$ Our) (NNS results)) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ-103 (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (DT the) (NN type) (CD II) (NN IL-1R)))) (VP (VBD was) (ADJP-PRD (JJ capable) (PP (IN of) (S (NP-SBJ (-NONE- *-103)) (VP-COOD (VP (ADVP (RB functionally)) (VBG interacting) (PP (IN with) (NP (NN interleukin-1)))) (CC and) (VP (VBG transmitting) (NP (DT the) (VBG resulting) (NN signal)) (PP (TO to) (NP (DT a) (JJ heterologous) (JJ cytoplasmic) (NN domain)))))))))))) (. .))
